PeriRx tackles development of saliva-based Rx cancer test; CryoLife resolves lawsuit

 @FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev

> Sanovas has secured its first U.S. patent toward the development of a device that would remove tissue growths and tumors "in hard-to-reach bodily cavities" to help treat lung cancer. Release

> PeriRx is developing a non-invasive saliva text that dentists can use to both detect and predict oral cancer. Story

> SQI Diagnostics in Toronto has raised the third and final tranche of a more than $5.65 million non-brokered private placement. Release

> CryoLife ($CRY), a medical device company focused on cardiac and vascular surgery, will receive $3.5 million as part of a settlement of its pending lawsuit against Medafor. Release

> Medical devicemakers are helping to boost demand for small businesses that make machines and components for other manufacturers, pointing to a positive sign for the broader economy. Story

> Boston Scientific's ($BSX) recent acquisition of Cameron Health brought the company a subcutaneous ICD, and MassDevice's Dr. Westby Fisher writes that the tech injects some much-needed originality into Boston Sci's CRM unit. Column

Biotech News

 @FierceBiotech: After death, some stem cells remain alive for days. More | Follow @FierceBiotech

 @RyanMFierce: Human Genome Sciences sets deadline of July 16 for acquisition offers, but not sure how that motivates non-GSK buyers. More | Follow @RyanMFierce

> Pfizer ramps up work with academics and biotech startups. Story

> HGS to GSK: Play by our buyout rules. More

> GSK grabs FDA nod for combo meningitis vax. News

> Bristol taps drug chemistry whizzes at Scripps. Article

Pharma News

 @FiercePharma: NICE tells Roche Zelboraf is too expensive. More | Follow @FiercePharma

> Feds nail Internet pharmacy operator for fake drugs. News

> HGS sets deadline for bids: Come and get it! Story

> Drugmakers line up for tsunami of diabetes. More

And Finally... Link-age, a 17-year-old Cincinnati-area nonprofit, is planning to raise as much as $20 million to establish a national venture fund focused on products and services relating to aging, the Business Courier reports. (sub. req.) Story